Intel's Terafab collaboration with SpaceX, xAI, and Tesla aimed to anchor 14A, but TSMC discussions introduce a potential second partner. No deal is announced; Musk’s openness to TSMC may shift leverage on economics, capacity, and timing. The stock dropped in premarket trading, signaling near-term risk if Terafab stalls or terms tighten.
Stocks rose as oil dropped, easing inflation fears and Treasury yields. Intel surged on reports SK Hynix may lease part of Intel’s Ohio fab or form a memory JV, fueling optimism on memory capacity and Xeon demand. If confirmed, the development could lift Intel’s trajectory and sustain a semis-led rally through the next few weeks.
Intel shares jumped about 10% amid a broad tech rally as chip stocks benefited from a risk-on market. The move appears driven by sentiment rather than company-specific news, suggesting short-term momentum for INTC but limited clarity on longer-term fundamentals. Investors should watch for follow-through and potential sector rotation that could sustain or fade the gain.
Jim Cramer highlighted a wave of short-dated call buying across memory and chip names, with Intel near-term bets seen around the $115 strike. The activity ties to a well-known hedge fund, though attribution remains unconfirmed. If sustained, the flow could support near-term volatility into October expiration, especially as Micron's results spark broader memory-name momentum.
Investors are eyeing a Fed rate decision while Intel climbs on a reported potential partnership with SK Hynix to build chips in the U.S. A confirmed tie-up could bolster Intel's U.S. manufacturing push and memory supply dynamics, but equities face macro headwinds from rate expectations and global trade tensions.
SK Hynix is in talks with Intel to manufacture memory chips on U.S. soil for the first time, per three people familiar with the discussions. While terms remain undisclosed, a formal arrangement would strengthen the U.S. memory supply chain and expand Intel's manufacturing ecosystem, with potential implications for capex and policy considerations. Market reaction will hinge on deal specifics and timing.